Effect of statins combined with PCSK9 inhibitors on the prognosis of patients with acute coronary syndromes after interventional therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Lu,Shi

第一单位： Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China. shiluzp@163.com.

作者： Lu,Shi ^[1] ; Zekang,Ye ^[2] ; Qian,Gu ^[3] ; Yong,Li ^[4]

作者单位： Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China. shiluzp@163.com. ^[1] Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China. yezekang@njmu.edu.cn. ^[2] Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China. Solsticeg@163.com. ^[3] Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China. liyong_edu@outlook.com. ^[4]

主题词人类(Humans);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);急性冠状动脉综合征(Acute Coronary Syndrome);治疗结果(Treatment Outcome)

DOI 10.14715/cmb/2023.69.12.41

PMID 38063128

发布时间 2023-12-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交